BioNTech
BNTX · NASDAQ
Bulios Fair Price
$113.59
17.4% upside
Preț actual
$96.73
Potrivit Bulios Fair Price, acțiunile BNTX sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Bulios Fair Price este o estimare a valorii corecte a unei acțiuni din modelul de evaluare Bulios. Este un punct de plecare pentru propria analiză, nu o recomandare de investiții. Cum funcționează?
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Despre companie
BioNTech SE is a German biotechnology company focused on the research and development of innovative drugs and therapeutic approaches. The company is well-known for its groundbreaking research and development of mRNA (messenger RNA) technology, which serves as the basis for drug and vaccine development. BioNTech collaborates with pharmaceutical and research partners worldwide and focuses on addressing serious diseases such as cancer, infectious diseases, and others. It gained significant recognition through its collaboration with Pfizer on the development and distribution of the COVID-19 vaccine, which became the first mRNA vaccine approved for emergency use. BioNTech SE adheres to high standards of scientific research and innovation and emphasizes the potential to change the way diseases are treated and prevented. Investing in BioNTech SE (BNTX) shares may be an interesting choice for investors who follow the biotechnology sector and seek investment opportunities in an innovative company with promising medical technologies.
Nu este încă disponibil în limba dumneavoastră, așa că textul este în engleză.
Sector
Healthcare
Industry
Biotechnology
CEO
Ugur Sahin
Employees
7,807
Headquarters
Mainz
Evenimente viitoare
Earnings
Upcoming earnings report